Filed before 2025Filed 17 December 2021
Glympse Bio, Inc. raised $18M
Glympse Bio, Inc., a biotech company based in Cambridge, MA, raised $18M in a new equity round, according to a filing dated 17 December 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 December 2021
- Round
- Equity round
- Amount sold
- $18M
- Offering size
- $18M
- Investors so far
- 12
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 61% of the 2,220 tracked raises with an amount filed in 2021, and than 46% of the 177 in biotech.
Glympse Bio, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 17 Dec 2021 | New filing | $18M | This raise |
| 1 Jul 2021 | Amended filing | $46.7M | Another raise |
| 12 Jun 2020 | New filing | $26.1M | Another raise |
| 6 Aug 2018 | New filing | $26.1M | Another raise |
More with Aspect Ventures on the board
- Arthur AI, Inc.$2.67M
- Writer, Inc.$200M
- Bryj Technologies Inc$5.29M
- HYCU Holdings, Inc.$29.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.